Aveo Capital Partners, LLC Danaher Corp Transaction History

Aveo Capital Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 06, 2023	SELL	$233.08 - $265.59 $7,225 - $8,233	-31 Reduced 2.23%	1,357 $336,000
Q2 2023 Aug 08, 2023	BUY	$224.99 - $256.14 $18,899 - $21,515	84 Added 6.44%	1,388 $333,000
Q1 2023 May 03, 2023	SELL	$239.75 - $277.0 $184,847 - $213,567	-771 Reduced 37.16%	1,304 $328,000
Q4 2022 Feb 03, 2023	BUY	$241.42 - $282.29 $110,328 - $129,006	457 Added 28.24%	2,075 $550,000
Q3 2022 Nov 09, 2022	BUY	$247.06 - $1507.4 $399,743 - $2.44 Million	1,618 New	1,618 $418,000

2,510

542M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $172B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Aveo Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Aveo Capital Partners, LLC with notifications on news.